W de Villiers

Statistics

Publications

Citations

248

H-Index

Active since

2006

Affiliations

Universitair Ziekenhuis Leuven(Current)

University of Kentucky

W de Villiers is an author at Universitair Ziekenhuis Leuven specializing in crohn disease pharmacotherapy, pharmacotherapy, and inflammatory bowel disease.

Publications per year

2006–2016

Publications

Fontolizumab in moderate to severe Crohnʼs disease: A phase 2, randomized, double-blind, placebo-controlled, multiple-dose study

Walter Reinisch, W de Villiers, László Bene et al. · Inflammatory Bowel Diseases · 2009 · 220 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Temporal gene expression profiles of target-ablated olfactory epithelium in mice with disrupted expression of scavenger receptor A: impact on macrophages

Marilyn L. Getchell, H. Li, Radhika Vaishnav et al. · Physiological Genomics · 2006 · 17 citations

Life Sciences, Immunology, Neuroscience +17

OC-057 A PH3 Randomised, Multicenter, Double-Blind, Placebo (PBO)-Controlled Study of Ustekinumab (UST) Maintenance Therapy in Moderate–Severe Crohn’s Disease (CD) PTS: Results from IM-UNITI

WJ Sandborn, B. Feagan, C Gasink et al. · 2016 · 11 citations

Medicine, Clinical Sciences, Pharmacotherapy +15

1–3 of 3